228.92
Overview
News
Price History
Option Chain
Financials
Why DHR Down?
Discussions
Forecast
Stock Split
Dividend History
Danaher Corp stock is traded at $228.92, with a volume of 1.27M.
It is down -0.76% in the last 24 hours and up +0.94% over the past month.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
See More
Previous Close:
$230.67
Open:
$230.9
24h Volume:
1.27M
Relative Volume:
0.33
Market Cap:
$161.70B
Revenue:
$24.27B
Net Income/Loss:
$3.50B
P/E Ratio:
47.11
EPS:
4.8589
Net Cash Flow:
$5.02B
1W Performance:
-1.10%
1M Performance:
+0.94%
6M Performance:
+15.89%
1Y Performance:
-0.27%
Danaher Corp Stock (DHR) Company Profile
Name
Danaher Corp
Sector
Industry
Phone
(202) 828-0850
Address
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DHR
Danaher Corp
|
228.92 | 162.93B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
TMO
Thermo Fisher Scientific Inc
|
579.45 | 219.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
IDXX
Idexx Laboratories Inc
|
676.53 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
136.07 | 39.02B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
225.41 | 38.78B | 15.90B | 1.28B | 2.21B | 7.2842 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Apr-10-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-21-25 | Upgrade | Goldman | Neutral → Buy |
| Mar-14-25 | Upgrade | Stifel | Hold → Buy |
| Feb-03-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-31-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-23 | Initiated | HSBC Securities | Hold |
| Dec-13-23 | Resumed | Wolfe Research | Peer Perform |
| Dec-07-23 | Downgrade | Goldman | Buy → Neutral |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-01-23 | Initiated | SVB Securities | Outperform |
| Apr-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-18-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Oct-24-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-17-22 | Resumed | Bernstein | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jun-01-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-11-22 | Initiated | Bernstein | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-10-21 | Reiterated | BofA Securities | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Reiterated | Goldman | Buy |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Apr-07-21 | Resumed | Robert W. Baird | Outperform |
| Mar-03-21 | Resumed | Barclays | Overweight |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-02-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-26-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-03-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Resumed | Stifel | Hold |
| Oct-28-19 | Reiterated | Needham | Buy |
| Oct-14-19 | Resumed | Credit Suisse | Outperform |
| Jul-19-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Feb-25-19 | Upgrade | Janney | Neutral → Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Apr-20-18 | Reiterated | Stifel | Buy |
View All
Danaher Corp Stock (DHR) Latest News
Single-Use Bioprocessing Products Market Set to Reach USD 36 - openPR.com
Vanderbilt University Takes Position in Danaher Corporation $DHR - MarketBeat
Allspring Global Investments Holdings LLC Raises Stock Holdings in Danaher Corporation $DHR - MarketBeat
Fortive Corp.: The Quiet Infrastructure Platform Powering the Next Industrial Upgrade - AD HOC NEWS
Danaher stock in focus: defensive quality meets cautious optimism as Wall Street updates its targets - AD HOC NEWS
Strength in Medical & Fluid Solutions Unit Drives Nordson: Can It Sustain? - TradingView — Track All Markets
Meridian Financial Partners LLC Takes $896,000 Position in Danaher Corporation $DHR - MarketBeat
Calamos Wealth Management LLC Has $16.98 Million Stake in Danaher Corporation $DHR - MarketBeat
Calamos Advisors LLC Sells 36,163 Shares of Danaher Corporation $DHR - MarketBeat
Best Biotech Stocks To Follow NowDecember 28th - MarketBeat
The Truth About Danaher Corp: Hidden Giant Every Investor Keeps Sleeping On - AD HOC NEWS
Biotech Stocks To ConsiderDecember 27th - MarketBeat
Simplify Asset Management Inc. Sells 10,166 Shares of Danaher Corporation $DHR - MarketBeat
Mirova US LLC Cuts Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Stock in Focus: Subtle Pullback, Strong Underlying Story - AD HOC NEWS
Cwm LLC Acquires 10,580 Shares of Danaher Corporation $DHR - MarketBeat
Danaher stock beats Wall Street dip as investors eye Fed minutes and Jan. 28 earnings - ts2.tech
Danaher (NYSE:DHR) Stock Little Changed in Life Sciences Sector - Kalkine Media
Danaher Corporation $DHR Position Increased by HM Payson & Co. - MarketBeat
Norris Perne & French LLP MI Has $15.08 Million Stake in Danaher Corporation $DHR - MarketBeat
Ethic Inc. Lowers Position in Danaher Corporation $DHR - MarketBeat
Biotech Stocks To Keep An Eye OnDecember 25th - MarketBeat
Manitou Investment Management Ltd. Sells 12,572 Shares of Danaher Corporation $DHR - MarketBeat
Baker Chad R Decreases Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Purchased by Exchange Traded Concepts LLC - MarketBeat
P/E Ratio Insights for Danaher - Benzinga
How Fresh Analyst Optimism On Bioprocessing At Danaher (DHR) Has Changed Its Investment Story - simplywall.st
Danaher (DHR) Stock After Hours on Dec. 24, 2025: What Happened After the Early Close — and What to Know Before the Next Market Open - ts2.tech
HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Finviz
Ex-Dividend Reminder: Medtronic, Danaher and DENTSPLY SIRONA - Nasdaq
James Hambro & Partners LLP Lowers Stock Holdings in Danaher Corporation $DHR - MarketBeat
Swedbank AB Reduces Stock Position in Danaher Corporation $DHR - MarketBeat
DAVENPORT & Co LLC Has $133.51 Million Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Best Biotech Stocks Worth WatchingDecember 18th - MarketBeat
Riverbridge Partners LLC Has $49.61 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
CCLA Investment Management Increases Holdings in Danaher Corporation $DHR - MarketBeat
Assenagon Asset Management S.A. Increases Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR is Arthur M. Cohen & Associates LLC's 6th Largest Position - MarketBeat
Zacks Research Has Strong Estimate for Danaher Q4 Earnings - MarketBeat
Goldman Sachs and KeyBanc are Bullish on Danaher (DHR) - Finviz
2025-12-21 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Danaher Corporation (DHR) and Encourages Shareholders to Learn More About the Investigation | NYSE:DHR | Press Release - Stockhouse
Goldman Sachs and KeyBanc are bullish on Danaher (DHR) - MSN
Foster Victor Wealth Advisors LLC Has $19.71 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Holdings Lowered by CHICAGO TRUST Co NA - MarketBeat
Douglas Lane & Associates LLC Acquires 73,352 Shares of Danaher Corporation $DHR - MarketBeat
Danaher (DHR): Revisiting Valuation as Earnings Grow While the Share Price Stalls - simplywall.st
Promising Biotech Stocks To Watch NowDecember 14th - MarketBeat
Danaher (NYSE:DHR) shareholders have endured a 0.9% loss from investing in the stock three years ago - Yahoo Finance
Louisbourg Investments Inc. Invests $4.26 Million in Danaher Corporation $DHR - MarketBeat
Aaron Wealth Advisors LLC Lowers Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp Stock (DHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):